| Literature DB >> 31548891 |
Flavio A Cadegiani1, Claudio E Kater1.
Abstract
BACKGROUND: Hormonal physiology in athletes, dysfunctional paths leading to overtraining syndrome (OTS), and clinical and biochemical behaviors that are independently modified by the presence of OTS remain unclear. Although multiple markers of OTS have recently been identified, the independent influence of OTS on hormones and metabolism have not been assessed. Hence, the objective of the present study was to uncover the previously unrecognized independent predictors of OTS and understand how OTS independently modifies the behaviors of clinical and biochemical parameters.Entities:
Keywords: Athletes; Conditioning; Endocrine and metabolic responses on overtraining syndrome (EROS) study; Overtraining syndrome; Performance
Year: 2019 PMID: 31548891 PMCID: PMC6751688 DOI: 10.1186/s13102-019-0132-x
Source DB: PubMed Journal: BMC Sports Sci Med Rehabil ISSN: 2052-1847
Markers included in the present analysis, among those evaluated by the EROS study
| Study/Tests | Markers | Whether included or excluded (and if excluded, why) |
|---|---|---|
| EROS-HPA axis |
|
|
| Basal ACTH and cortisol and their response to an insulin tolerance test (ITT) | 1. Basal cortisol (μg/dL) 2. Cortisol during hypoglycemia (μg/dL) 3. Cortisol 30 min after hypoglycemia (μg/dL) 4. Cortisol increase during ITT (μg/dL) 5. Basal ACTH (pg/mL) 6. ACTH during hypoglycemia (pg/mL) 7. ACTH 30 min after hypoglycemia (pg/mL) 8. ACTH increase during ITT (pg/mL) 9 Basal ACTH/cortisol ratio 10. ACTH/cortisol ratio during hypoglycemia 11. ACTH/cortisol ratio 30 min after hypoglycemia | Similar levels between OTS and ATL INCLUDED INCLUDED INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED INCLUDED Unsubstantiated marker Unsubstantiated marker Unsubstantiated marker (although different between OTS and ATL) |
| Cortisol response to a | 12. Cortisol at 30 min after synthetic ACTH shot (μg/dL) 13. Cortisol at 60 min after synthetic ACTH shot (μg/dL) 14. Difference between basal cortisol on day 1 (CST) and day 3 (ITT) (%) | Similar levels between OTS and ATL Similar levels between OTS and ATL Not diagnostic or helpful |
| Salivary cortisol rhythm (SCR) | 15. Salivary cortisol at awakening (ng/dL) 16. Salivary cortisol 30 min after wakening (ng/dL) 17. Salivary cortisol at 4 PM (ng/dL) 18. Salivary cortisol at 11 PM (ng/dL) 19. Cortisol awakening response (CAR) (%) 20. Difference between 8 AM and 4 PM salivary cortisol (%) | Similar levels between OTS and ATL INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED Not diagnostic or helpful |
| EROS-STRESS |
|
|
| GH and Prolactin response to an ITT | 1. Basal (GH) (μg/L) 2. GH during hypoglycaemia (μg/L) 3. GH 30 min after hypoglycaemia (μg/L) 4. Basal prolactin (ng/mL) 5. Prolactin during hypoglycaemia (ng/mL) 6. Prolactin 30 min after hypoglycaemia (ng/mL) 7. Prolactin increase during ITT (ng/mL) 8. Basal serum glucose (mg/dL) 9 Serum glucose during hypoglycemia (mg/dL) 10. Capillary glucose during hypoglycemia (mg/dL) 11. Adrenergic symptoms during hypoglicemia (0–10) 12. Neuroglycopenic symptoms during hypoglicemia (0–10) | INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful (although different between OTS and ATL) Not diagnostic or helpful |
| EROS-BASAL |
|
|
| Hormonal markers | 1. Total testosterone (ng/dL) 2. Estradiol (pg/mL) 3. IGF-1 (pg/mL) 4. TSH (μUI/mL) 5. Free T3 (pg/mL) 6. Total catecholamines (μg/12 h) 7. Total metanephrines (μg/12 h) 8. Noradrenaline (μg/12 h) 9. Epinephrine (μg/12 h) 10. Dopamine (μg/12 h) 11. Metanephrine (μg/12 h) 12. Normetanephrine (μg/12 h) 13. Catecholamine-to-metanephrine ratio | INCLUDED INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL Not diagnostic or helpful (although diferente between OTS and ATL) |
| Biochemical markers | 14. Erythrocyte sedimentation rate (ESR, mm/h) 15. Hematocrit (%) 16. C-reactive protein (CRP, mg/dL) 17. Lactate (nMol/L) 18. Vitamin B12 (pg/mL) 19. Ferritin (ng/mL) 20. Neutrophils (*mm3) 21. Lymphocyte (*mm3) 22. Eosinophils (*mm3) 23. Creatine kinase (CK, U/L) 24. Medium corpuscular volume (MCV) 25. Platelets (103/mm) 26. Low density lipoprotein cholesterol (LDLc) (mg/dL) 27. High density lipoprotein cholesterol (HDLc) (mg/dL) 28. Tryglicerides (mg/dL) | Similar levels between OTS and ATL Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED Similar levels between OTS and ATL Similar levels between OTS and ATL INCLUDED Not diagnostic or helpful Not diagnostic or helpful Data missed in > 5% of participants Data missed in > 5% of participants Data missed in > 5% of participants |
| Ratios | 29. Testosterone-to-oestradiol ratio 30. Testosterone-to-cortisol ratio 31. Neutrophil-to-lymphocyte ratio 32. Platelet-to-lymphocyte ratios | INCLUDED Similar levels between OTS and ATL INCLUDED Similar levels between OTS and ATL |
| EROS-PROFILE |
|
|
| Nutritional patterns (7-day diet record, prior and during OTS) | 1. Calorie intake (kcal/kg/day) 2. Carbohydrate intake (g/kg/day) 3. % calories from carbohydrate (%) 4. Protein intake (g/kg/day) 5. % calories from protein (%) 6. Fat intake (g/kg/day) 7. % calories from fat (%) 8. Carbohydrate intake > 3 g/kg/day (Y/N) 9. Daily whey protein consumption (Y/N) 10. Followed a diet plan (Y/N) 11. Post-workout carbohydrate intake > 0.5 g/kg (Y/N) | INCLUDED (as a modifiable habita) INCLUDED (as a modifiable habita) Intrinsically linked to other parameters INCLUDED (as a modifiable habita) Intrinsically linked to other parameters Similar levels between OTS and ATL Intrinsically linked to other parameters Qualitative marker Qualitative marker Qualitative marker Qualitative marker |
| Psychological patterns (during OTS) | 12. Profile of Mood State (POMS) questionnaire (total score: −32 to + 120) 13. Anger subscale (0 to 48) 14. Confusion subscale (0 to 28) 15. Depression subscale (0 to 60) 16. Vigour subscale (0 to 32) 17. Fatigue subscale (0 to 28) 18. Tension subscale (0 to 36) 19. How do you fell today? (0–10) 20. Have you been sick in the last two weeks? (Y/N)? 21. How was your last training session compared to the projected goals? (Extremely easy to extremely hard) 22. How do your muscles feel? (Nothing at all to extremely painful) 23. How friendly do you feel today? (0–6) 24. How worthless do you feel today? (0–6) 25. How miserable do you feel today? (0–6) 26. How helpful do you feel today? (0–6) 27. How bad-tempered do you feel today? (0–6) 28. How unworthy do you feel today? (0–6) 29. How peeved do you feel today? (0–6) 30. How cheerful do you feel today? (0–6) 31. How sad do you feel today? (0–6) 32. Number of hours of activities besides professional training (h/day) | INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED Not diagnostic or helpful (although different between OTS and ATL) Qualitative marker Not diagnostic or helpful (although different between OTS and ATL) Not diagnostic or helpful (although different between OTS and ATL) Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful (although different between OTS and ATL) Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful (although different between OTS and ATL) Not diagnostic or helpful INCLUDED (as a modifiable habita) |
| Social patterns (during OTS) | 33. Duration of night sleep (h) 34. Self-reported sleep quality (0–10) 35. Self-reported libido (0–10) 36. Initial imnsonia (Y/N) 37. Terminal imnsonia (Y/N) 38. More than two wake-ups during sleep (Y/N) 39. Work and/or study (Y/N) 40. Libido during resting periods / vacations (0–10) | Similar levels between OTS and ATL INCLUDED (as a modifiable habita) INCLUDED Qualitative marker Qualitative marker Qualitative marker Qualitative marker Not diagnostic or helpful |
| Body metabolism analysis (indirect calorimetry) | 41. Measured-to-predicted basal metabolic rate (BMR, %) 42. Percentage of fat burning compared to total BMR (%) | INCLUDED INCLUDED |
| Body composition (Bod Pod, InBody770 and 3D body scanner) | 43. Body fat percentage (%) 44. Visceral fat (cm2) 45. Muscle mass weight (%) 46. Body water percentage (BW, %) 47. Extracellular water compared to total BW (%) 48. Body weight (kg) 49.Chest to waist circumference 50. Waist circumference (cm) 51. Chest circumference (cm) 52. Biceps circumference (cm) 53. Hip circumference (cm) | INCLUDED INCLUDED INCLUDED INCLUDED INCLUDED Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful Not diagnostic or helpful |
OTS Athletes affected by overtraining syndrome, ATL, Healthy athletes
aFor statistical purposes, modifiable factors were considered as independent variables, from which the dependent variables were statistically evaluated
Fig. 1Variables included in the present analysis
Independent triggers of OTS
|
| Independent variables included | Results (* = positive for independent risk factors and triggers) | Interpretation |
|---|---|---|---|
| CHO, PROT, CAL, WORK, SLEEP | PERFECT SEPARATION | Together, modifiable patterns were able to explain all cases of OTS in the athletes studied. | |
| CHO, PROT, CAL, SLEEP | PERFECT SEPARATION | Dietary patterns together with sleep quality were also able to fully explain all cases of OTS in the studied population of athletes. | |
| CHO, PROT, WORK, SLEEP | CHO: OR/CL = 1.61 (1.03–2.50) PROT: OR/CL = 16.7 (1.34–208.1) WORK: p = n/s SLEEP: OR/CL = 2.19 (0.94–5.09) | When daily caloric intake is not accounted, not all cases of OTS may be justified. However, in this scenario both CHO and PROT were shown to be independent triggers of OTS. | |
| CAL, WORK, SLEEP | CAL: OR/CL = 1.13 (1.04–1.23) WORK: p = n/s SLEEP: p = n/s | When each macronutrient intake is not specified, not all cases of OTS may be justified. However, in this scenario CAL was enough to independent etiology of OTS. | |
| CHO, PROT, CAL | CHO: p = n/s PROT: OR/CL = 25.85 (0.81–825.3) CAL: OR/CL = 1.27 (1.01–1.61) | When only dietary patterns are evaluated, we cannot explain all cases of OTS in the studied population. However, in this scenario, overall caloric intake, but not each macronutrient, was able to |
CHO Daily carbohydrate intake (g/kg/day), PROT Daily protein intake (g/kg/day), CAL Mean daily caloric intake (kcal/kg/day), WORK Average number of working or studying hours a day, besides training sessions (h/day), SLEEP Self-reported sleep quality (0–10), OTS Overtraining syndrome, OR Odds ratio, CL 95% Confidence Limits, p Level of significance, n/s non-significant (p > 0.1)
Clinical and biochemical behaviors independently modified by overtraining syndrome (OTS)
| Parameters modified by the presence of OTS | Level of influence of the presence of OTS a | Other variables that may also influence | Equation for the estimation of the parameter level in male athletes | |
|---|---|---|---|---|
| Late ACTH response to an ITT (30’after hypoglycaemia) (pg/mL) | 0.002 | 19.9% |
|
|
| Late cortisol response (30’after hypoglycaemia) (μg/dL) | 0.0005 | 26.1% |
| Cortisol (μg/dL) = 17.86–3.81(if OTS) |
| Cortisol response to an ITT (μg/dL) | 0.002 | 22.0% |
|
|
| Late GH response (30’after hypoglycaemia) (μg/L) | 0.001 | 23.0% |
|
|
| Testosterone-to-oestadiol ratio (T/E) | 0.0002 | 30.7% |
| T/E = 14.1 + 12.9 (if OTS) |
| POMS vigour subscale | < 0.0001 | 83.6% | Sleep quality | POMS vigour subscale = 3.7 + 1.15x(sleep quality) – 11.96(if OTS) |
| POMS fatigue subscale | < 0.0001 | 85.7% | Sleep quality | POMS fatigue subscale = 24.5–0.9 x(sleep quality) + 15.3(if OTS) |
| POMS tension subscale | < 0.0001 | 42.8% |
| Not able to be estimated |
| Visceral fat (cm2) | 0.002 | 38.2% | Protein and overall calorie intake | Visceral fat = 47.4–11.9x(protein intake) + 1.3x(calorie intake) + 45.1(if OTS) |
| Muscle mass (%) | 0.028 | 33.7% | Protein intake | Muscle mass = 47.84 + 1.42x(protein intake) – 3.47(if OTS) |
| Body water (%) | 0.001 | 50.5% | Protein and overall calorie intake | Body water = 60.75 + 1.69x(protein intake) – 0.12x(calorie intake) - 5.77(if OTS) |
| Neutrophils (/mm3) | 0.015 | 13.8% | Calorie intake | Neutrophils = 4210–60.7x(calorie intake) + 154.4x(CHO intake) -1724(if OTS) |
| Neutrophil-to-lymphocyte ratio | 0.015 | 13.6% |
| Ratio = 2.00–1.32(if OTS) |
CHO Carbohydrate, ITT Insulin tolerant test, POMS Profile of mood states, BMR Basal metabolic rate, T/E Testosterone-to-oestradiol, OTS Overtraining syndrome’, n/a non applicables (non-normal distribution)
Calorie intake = kcal/kg/day, CHO intake = g(CHO)/kg/day; protein intake = g(protein)/kg/day; extra activities = working and/or studying hours besides training, sleep quality = self-reported sleep quality (0 to 10)
aOther minor influences may also reflect the p-value and the level of influence
Fig. 2Summary of the predictions of Overtraining syndrome (OTS) and its implications